From the Collaborative Bond and Money Market Data Portal
The Biotechnology Industry Sector comprises companies that are primarily engaged in the research, development, manufacturing and/or marketing of products based on genetic analysis and genetic engineering. This sector includes companies specializing in protein-based therapeutics to treat human diseases.
The Industry Sector is a classification that describes the activity of an entity within the economy. The classification is based on where the relevant entity derives the majority of its revenue.
In the Collaborative Bond and Money Market Data Model the Biotechnology Industry Sector appears within the Industry Sector Type: Corporate.
CMDportal uses industry sector classifications both at the Legal Entity level, as well as at the Group level. At the Legal Entity level the entity is classified by their actual industry activity. Accordingly, we classify a finance company that is part of a Biotechnology conglomerate as a financial corporate at the entity level but at the group level as an Biotechnology company.
Based on available data, on the 18th of April 2018 the size of the Biotechnology Bond Market at entity level was USD58bn equivalent. At the group level the size of the market was USD113bn equivalent.
For information on the size of the Biotechnology Bond Market, please use our data sheet tool.
For information on the composition of the Biotechnology Bond Market, please use our issuer search tool.
For information on active dealers in the Biotechnology Bond Market, please use our dealer search tool.
For information on active investors in the Biotechnology Bond Market, please use our investor search tool.